Published in Acta Derm Venereol on May 01, 1997
Substantial alterations of the cutaneous bacterial biota in psoriatic lesions. PLoS One (2008) 3.56
Studies on topical antiperspirant control of axillary hyperhidrosis. Acta Derm Venereol (1975) 3.00
New staining techniques for the Langerhans cell. Acta Derm Venereol (1977) 2.37
Group A streptococcal growth phase-associated virulence factor regulation by a novel operon (Fas) with homologies to two-component-type regulators requires a small RNA molecule. Mol Microbiol (2001) 2.24
Cloning, sequence analysis, and expression in Escherichia coli of a streptococcal plasmin receptor. J Bacteriol (1992) 2.14
Generalized Trichophyton rubrum infection in congenital ichthyosiform erythroderma. J Am Acad Dermatol (1989) 2.04
Association between expression of immunoglobulin G-binding proteins by group A streptococci and virulence in a mouse skin infection model. Infect Immun (1993) 1.92
Coexistent erythrasma, trichomycosis axillaris, and pitted keratolysis: an overlooked corynebacterial triad? J Am Acad Dermatol (1982) 1.87
Botulinum toxin therapy for palmar hyperhidrosis. J Am Acad Dermatol (1998) 1.85
Capturing host plasmin(ogen): a common mechanism for invasive pathogens? Trends Microbiol (1994) 1.76
Identification of a specific receptor for plasmin on a group A streptococcus. Infect Immun (1987) 1.72
M-related protein (Mrp) contributes to group A streptococcal resistance to phagocytosis by human granulocytes. Mol Microbiol (1996) 1.71
Nonpigmenting fixed drug eruption as a distinctive reaction pattern: examples caused by sensitivity to pseudoephedrine hydrochloride and tetrahydrozoline. J Am Acad Dermatol (1987) 1.64
Langerhans cells form a reticuloepithelial trap for external contact antigens. Nature (1976) 1.61
A dermatologic diary. Portrait of a practice. Cutis (1991) 1.40
Identification of pel, a Streptococcus pyogenes locus that affects both surface and secreted proteins. J Bacteriol (1999) 1.39
Isolation of a prokaryotic plasmin receptor. Relationship to a plasminogen activator produced by the same micro-organism. J Biol Chem (1991) 1.38
The dentate tongue as a manifestation of tension. J Am Acad Dermatol (1986) 1.38
A secreted streptococcal cysteine protease can cleave a surface-expressed M1 protein and alter the immunoglobulin binding properties. Res Microbiol (1998) 1.36
Streptococcal Fc receptors. I. Isolation and partial characterization of the receptor from a group C streptococcus. J Immunol (1984) 1.33
Selective uptake of contact allergens by the Langerhans cell. Arch Dermatol (1977) 1.26
Comparative in vitro activities of N-formimidoyl thienamycin and moxalactam against nonfermentative aerobic gram-negative rods. Antimicrob Agents Chemother (1982) 1.22
Analysis of genes encoding two unique type IIa immunoglobulin G-binding proteins expressed by a single group A streptococcal isolate. Infect Immun (1994) 1.20
Characterization of the interaction of human plasmin with its specific receptor on a group A streptococcus. Microb Pathog (1988) 1.20
Isolation and characterization of type IIa and type IIb Fc receptors from a group A streptococcus. Scand J Immunol (1986) 1.18
Occurrence and expression of imipemide (N-formimidoyl thienamycin) resistance in clinical isolates of coagulase-negative staphylococci. Antimicrob Agents Chemother (1983) 1.16
Effect of mouse passage on Fc receptor expression by group A streptococci. Scand J Immunol (1984) 1.15
Streptokinase-producing streptococci grown in human plasma acquire unregulated cell-associated plasmin activity. J Infect Dis (1992) 1.15
Absence of SpeB production in virulent large capsular forms of group A streptococcal strain 64. Infect Immun (2000) 1.13
Immune basophil degranulation: detection by iodonitrotetrazolium dehydrogenase stain. Int Arch Allergy Appl Immunol (1974) 1.13
Identification of non-immunoglobulin A-Fc-binding forms and low-molecular-weight secreted forms of the group B streptococcal beta antigen. Infect Immun (1989) 1.12
Protection of mice from group A streptococcal skin infection by interleukin-12. J Infect Dis (1995) 1.12
Empirical use of imipenem as the sole antibiotic in the treatment of serious infections. J Antimicrob Chemother (1985) 1.12
Association of type II immunoglobulin G-binding protein expression and survival of group A streptococci in human blood. Infect Immun (1993) 1.10
125I protein A: applications to the quantitative determination of fluid phase and cell-bound IgG. J Immunol Methods (1977) 1.10
Electron microscopy, histochemistry, and microbiology of bacterial adhesion in trichomycosis axillaris. J Am Acad Dermatol (1984) 1.10
Studies on the terminal stages of immune hemolysis. VI. Osmotic blockers of differing Stokes' radii detect complement-induced transmembrane channels of differing size. J Immunol (1979) 1.09
Experimental disease in the skin of man. A review. Acta Derm Venereol Suppl (Stockh) (1982) 1.09
Functional and serological analysis of type II immunoglobulin G-binding proteins expressed by pathogenic group A streptococci. J Clin Microbiol (1992) 1.08
Two novel antigens associated with group B streptococci identified by a rapid two-stage radioimmunoassay. J Infect Dis (1988) 1.07
Aminogenic alopecia. Trans Assoc Am Physicians (1966) 1.07
Measurement of leukocyte chemotaxis in vivo. Methods Enzymol (1988) 1.07
Isolation and partial characterization of a type II Fc receptor from a group A streptococcus. Mol Cell Biochem (1986) 1.07
Hydroxyurea in the treatment of pustular psoriasis. Br J Dermatol (1971) 1.06
Streptococcal Fc receptors. II. Comparison of the reactivity of a receptor from a group C streptococcus with staphylococcal protein A. J Immunol (1984) 1.06
Evidence for functional heterogeneity in IgG Fc-binding proteins associated with group A streptococci. J Immunol (1991) 1.05
Polysorbate 80 hypersensitivity. Lancet (1995) 1.05
Group B streptococcal C protein-associated antigens: association with neonatal sepsis. J Infect Dis (1991) 1.04
Pincer nail syndrome. Arch Surg (1968) 1.02
Mapping of the human plasmin domain recognized by the unique plasmin receptor of group A streptococci. Infect Immun (1989) 1.02
Identification of two type IIa IgG-binding proteins expressed by a single group A streptococcus. J Immunol (1992) 1.02
Studies on the terminal stages of immune hemolysis. III. Distinction between the insertion of C9 and the formation of a transmembrane channel. J Immunol (1978) 1.02
Role of emm and mrp genes in the virulence of group A streptococcal isolate 64/14 in a mouse model of skin infection. J Infect Dis (1998) 1.01
Generalized pustular psoriasis induced by potassium iodide. A postulated role for dihydrofolic reductase. JAMA (1967) 1.01
Cold urticaria with cryoglobulinemia in a patient with chronic lymphocytic leukemia. Arch Dermatol (1968) 1.01
Interaction between group A streptococci and the plasmin(ogen) system promotes virulence in a mouse skin infection model. J Infect Dis (1999) 0.99
Properties of IgG-binding proteins expressed by Streptococcus pyogenes isolates are predictive of invasive potential. J Infect Dis (1996) 0.99
Demonstration of a unique viral structure: the molluscum viral colony sac. Br J Dermatol (1986) 0.99
Isolated DNA repeat region from fcrA76, the Fc-binding protein gene from an M-type 76 strain of group A streptococci, encodes a protein with Fc-binding activity. Mol Microbiol (1990) 0.99
Detection of receptors for the Fc region of IgG on streptococci. J Immunol Methods (1983) 0.99
Identification of a unique receptor on a group A streptococcus for the Fc region of human IgG3. J Immunol (1986) 0.98
A role for fibrinogen in the streptokinase-dependent acquisition of plasmin(ogen) by group A streptococci. J Infect Dis (1995) 0.98
High dose dapsone toxicity. Br J Dermatol (1976) 0.98
The potential role for nephritis-associated plasmin receptor in acute poststreptococcal glomerulonephritis. Methods (2000) 0.98
A group A streptococcal Enn protein potentially resulting from intergenomic recombination exhibits atypical immunoglobulin-binding characteristics. Mol Microbiol (1994) 0.97
Bacterial endotoxin (lipopolysaccharide) as a cause of erythema multiforme. JAMA (1980) 0.97
Analysis of the interaction of group A streptococci with fibrinogen, streptokinase and plasminogen. Microb Pathog (1995) 0.97
Mycobacterium gordonae infection of the hand. Arch Dermatol (1984) 0.97
Giant Langerhans cells induced by psoralen and ultraviolet radiation. Arch Dermatol Res (1979) 0.96
The patch test. JAMA (1967) 0.96
Studies on the interaction between protein A and immunoglobulin G. II. Composition and activity of complexes formed between protein A and IgG. J Immunol (1978) 0.96
Studies on the terminal stages of immune hemolysis. V. Evidence that not all complement-produced transmembrane channels are equal. J Immunol (1979) 0.96
Nerve growth factor: a chemotactic factor for polymorphonuclear leukocytes in vivo. J Immunol (1985) 0.96
Differences in cell-bound C8 sites on chicken erythrocytes measured by their reactivity with guinea pig and human C9. J Immunol (1980) 0.95
Identification of key gene products required for acquisition of plasmin-like enzymatic activity by group A streptococci. J Infect Dis (1997) 0.95
The Langerhans cell: its origin, nature, and function. Acta Derm Venereol Suppl (Stockh) (1978) 0.95
The fish odor syndrome. Trimethylaminuria. JAMA (1984) 0.95
Mouse skin passage of a Streptococcus pyogenes Tn917 mutant of sagA/pel restores virulence, beta-hemolysis and sagA/pel expression without altering the position or sequence of the transposon. BMC Microbiol (2001) 0.95
Lysis of tumor cells by antibody and complement. VII. Complement-dependent 86Rb release--a nonlethal event? J Immunol (1976) 0.94
Nonmetastatic cutaneous manifestations of cancer of the colon. Am J Surg (1969) 0.94
Nerve growth factor: stimulation of polymorphonuclear leukocyte chemotaxis in vitro. Proc Natl Acad Sci U S A (1983) 0.94
Production of Brucella abortus-specific protein A-reactive antibodies (IgG2) in infected and vaccinated cattle. Vet Microbiol (1986) 0.94
Analysis of plasmin(ogen) acquisition by clinical isolates of group A streptococci incubated in human plasma. J Infect Dis (1994) 0.94
What is the biological basis of pattern formation of skin lesions? Exp Dermatol (2006) 0.93
Urokinase: a chemotactic factor for polymorphonuclear leukocytes in vivo. J Immunol (1987) 0.93
Fluorescent staining of elastic tissue with Rhodamine B and related xanthene dyes. Histochemie (1969) 0.92
A simple procedure to use whole serum as a source of either IgG- or IgM-specific antibody. J Immunol Methods (1980) 0.92
Studies on the terminal stages of antibody-complement-mediated killing of a tumor cell. II. Inhibition of transformation of T to dead cells by 3'5' cAMP. J Immunol (1976) 0.92
Surgical treatment of farmyard pox. Orf, milker's nodules, bovine papular stomatitis pox. Cutis (1983) 0.92
Detection of histamine by a new fluorescent omicron-phthalaldehyde stain. J Histochem Cytochem (1966) 0.91
Staphylococcus aureus colonization of burrows in erythrodermic Norwegian scabies. A case study of iatrogenic contagion. J Am Acad Dermatol (1988) 0.91
Similarities between complement-mediated and streptolysin S-mediated hemolysis. J Biol Chem (2001) 0.91
Detection of protein A-like substances on haemolytic streptococci prior to use in mixed reverse passive antiglobulin haemagglutination (MRPAH). J Immunol Methods (1979) 0.90